EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes

Roman Tremmel, Daniel Hübschmann, Elke Schaeffeler, Sebastian Pirmann, Stefan Fröhling, Matthias Schwab

Pharmacological Reviews · 2025

DOI: 10.1124/pharmrev.124.001049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Reviews, 2025. Verfasst von Roman Tremmel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 360 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansPrecision MedicinePharmacogeneticsGerm-Line MutationAnimals

Stichwörter der Autor:innen

Cytochrome P450 (CYP)Transporter-mediated drug/metabolite dispositioncancercytochrome P450 functionclinical pharmacologypharmacogenetics/pharmacogenomicsdrug efficacydrug

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany.
  • Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between the German Cancer Research Center (DKFZ) and Heidelberg University Hosp…
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tuebingen, Tuebingen, Germany; Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Thera…
  • German Cancer Consortium (DKTK), DKFZ, Core Center Heidelberg, Heidelberg, Germany; Division of Translational Medical Oncology, DKFZ, Heidelberg, Germany; NCT Heidelberg, a partnership between DKFZ and Heidelberg Univer…

Zitieren

APA

Tremmel, R., Hübschmann, D., Schaeffeler, E., Pirmann, S., Fröhling, S., & Schwab, M. (2025). Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes. Pharmacological Reviews. https://doi.org/10.1124/pharmrev.124.001049

Vancouver

Tremmel R, Hübschmann D, Schaeffeler E, Pirmann S, Fröhling S, Schwab M. Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes. Pharmacological Reviews. 2025. doi:10.1124/pharmrev.124.001049

BibTeX
@article{Tremmel2025,
  author = {Tremmel, Roman and Hübschmann, Daniel and Schaeffeler, Elke and Pirmann, Sebastian and Fröhling, Stefan and Schwab, Matthias},
  title = {Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes},
  journal = {Pharmacological Reviews},
  year = {2025},
  doi = {10.1124/pharmrev.124.001049}
}
Kostenlos starten →